Effects of Multimodal Analgesia on Monocyte Chemoattractant Protein-1, Brain-derived Neurotrophic Factor, and RNA-124 Micro to Acute Pain in Patients Who Underwent Hysterectomy
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 62
- 试验地点
- 1
- 主要终点
- Preoperative MiRNA-124
研究概览
简要总结
The inflammatory process is the main mechanism in the occurrence of acute postoperative pain. It is also the main risk for the development of acute pain into persistent pain. Inflammation occurs in the process of peripheral sensitization and central sensitization with various inflammatory mediators. Postoperatively, there will be proliferation and activation of microglia and astrocytes which will then activate inflammatory receptors and signaling cascades of neurotransmitters, cytokines, and chemokines. There has been a lot of clinical research evidence that multimodal analgesia can adequately treat acute pain and can prevent the development of acute postoperative pain into persistent pain and chronic postoperative pain, but the molecular mechanisms are not fully understood.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years(Adult, Older Adult)
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Scheduled for elective hysterectomy
- •American Society of Anesthesiologists (ASA) physical status 1 to 3
排除标准
- •allergy to studied drugs
- •history of chronic pain
- •history of hepatitis, depression, peptic ulcer, or acute myocardial infarction
- •receive intraoperative massive blood transfusion
- •prolonged coagulation
- •body mass index >35 kg/m2
- •patients with neurological deficits
- •taking anti-platelet medications
研究组 & 干预措施
Hysterectomy
Patients who undergo surgical hysterectomy that fits inclusion and exclusion criteria
干预措施: Multimodal analgesia (Drug)
Hysterectomy
Patients who undergo surgical hysterectomy that fits inclusion and exclusion criteria
干预措施: Conventional intravenous analgesia (Drug)
结局指标
主要结局
Preoperative MiRNA-124
时间窗: 1-hour before surgery
serum level of MiRNA-124
Preoperative MCP-1
时间窗: 1-hour before surgery
serum level of MCP-1
Preoperative BDNF
时间窗: 1-hour before surgery
serum level of BDNF
Postoperative MCP-1
时间窗: 48-hours after surgery
serum level of MCP-1
Postoperative BDNF
时间窗: 48-hours after surgery
serum level of BDNF
Postoperative MiRNA-124
时间窗: 48-hours after surgery
serum level of MiRNA-124
次要结局
未报告次要终点
研究者
Christopher Ryalino, MD
Principal Investigator
Udayana University
